Literature DB >> 29465000

Long non-coding RNA FENDRR reduces prostate cancer malignancy by competitively binding miR-18a-5p with RUNX1.

Guanying Zhang1, Guangye Han1, Xinjun Zhang2, Quanfeng Yu1, Zeyu Li1, Zhenhui Li1, Jianchang Li2.   

Abstract

CONTEXT: Prostate cancer (PCa) is one of the most commonly diagnosed malignancy in men in the western world.
OBJECTIVE: We aim to investigate the biological role of long non-coding RNA FENDRR and its mechanism in PCa.
MATERIALS AND METHODS: We determined the expression of FENDRR and miR-18a-5p in PCa tissues and examined the regulatory mechanism in PCa cell lines.
RESULTS: FENDRR transcripts in human PCa tissues were significantly decreased compared with the normal controls. Reduced expression of FENDRR was correlated with the increase of pathological degree and poor prognosis in PCa patients. Upregulation of FENDRR inhibited cell proliferation, increased apoptosis and decreased invasion and migration ability, which was inhibited by miR-18a-5p mimic. Knockdown of FENDRR resulted in a significant increase of PCa cell proliferation and decrease of apoptosis and this effect was inhibited miR-18a-5p inhibitor. FENDRR and RUNX1 contain potential target sites for miR-18a-5p. miR-18a-5p mimic inhibited RUNX1 expression and luciferase activity. FENDRR could increase RUNX1 expression, which was inhibited by miR-18a-5p. The effect of FENDRR on cell proliferation, apoptosis and invasion and migration ability was suppressed by silence of RUNX1. DISCUSSION AND
CONCLUSION: These results position FENDRR/miR-18a-5p/RUNX1 as a potential therapeutic target and biomarker for PCa.

Entities:  

Keywords:  FENDRR; Prostate cancer; RUNX1; malignancy; miR-18a-5p

Mesh:

Substances:

Year:  2018        PMID: 29465000     DOI: 10.1080/1354750X.2018.1443509

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  22 in total

1.  LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.

Authors:  Xinglei Qin; Min Lu; Yajun Zhou; Gang Li; Zhaoyang Liu
Journal:  Cell Cycle       Date:  2019-04-14       Impact factor: 4.534

Review 2.  Good or not good: Role of miR-18a in cancer biology.

Authors:  Tomasz Kolenda; Kacper Guglas; Magda Kopczyńska; Joanna Sobocińska; Anna Teresiak; Renata Bliźniak; Katarzyna Lamperska
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-12

3.  Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.

Authors:  Tianyu Zhai; Dilidaer Muhanhali; Xi Jia; Zhiyong Wu; Zhenqin Cai; Yan Ling
Journal:  Endocrine       Date:  2019-07-22       Impact factor: 3.633

4.  Identification of long intergenic non-coding RNAs (lincRNAs) deregulated in gastrointestinal stromal tumors (GISTs).

Authors:  Ugne Gyvyte; Juozas Kupcinskas; Simonas Juzenas; Ruta Inciuraite; Lina Poskiene; Violeta Salteniene; Alexander Link; Matteo Fassan; Andre Franke; Limas Kupcinskas; Jurgita Skieceviciene
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

5.  MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.

Authors:  Xiaodong Wang; Jian Lu; Jisen Cao; Bozhao Ma; Chao Gao; Feng Qi
Journal:  Onco Targets Ther       Date:  2018-11-09       Impact factor: 4.147

6.  Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.

Authors:  Chiara Formica; Tareq Malas; Judit Balog; Lotte Verburg; Peter A C 't Hoen; Dorien J M Peters
Journal:  J Mol Med (Berl)       Date:  2019-11-26       Impact factor: 4.599

7.  lncRNA WT1-AS inhibits the aggressiveness of cervical cancer cell via regulating p53 expression via sponging miR-330-5p.

Authors:  LiJuan Cui; ManMan Nai; Ke Zhang; Lu Li; RuiMin Li
Journal:  Cancer Manag Res       Date:  2019-01-11       Impact factor: 3.989

8.  FENDRR suppresses cervical cancer proliferation and invasion by targeting miR-15a/b-5p and regulating TUBA1A expression.

Authors:  Yunheng Zhu; Xiaohua Zhang; Lifeng Wang; Xiuxiang Zhu; Ziyin Xia; Ling Xu; Jun Xu
Journal:  Cancer Cell Int       Date:  2020-05-06       Impact factor: 5.722

Review 9.  Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies.

Authors:  Keisaku Sato; Shannon Glaser; Heather Francis; Gianfranco Alpini
Journal:  Front Med (Lausanne)       Date:  2020-02-20

10.  Long non-coding RNA FENDRR regulates IFNγ-induced M1 phenotype in macrophages.

Authors:  Maria Cristina Munteanu; Chaoqun Huang; Yurong Liang; Roshini Sathiaseelan; Xiangming Zeng; Lin Liu
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.